Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus [Seeking Alpha]
GEMPHIRE THERAPEUTICS INC COMMON (GEMP)
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.gemphire.com
Company Research
Source: Seeking Alpha
Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus Summary My last two articles on Gemphire Therapeutics focused on the scientific and clinical errors that have delayed the clinical development of its lead investigative drug candidate, Gemcabene. I previously explained why the FDA's partial clinical hold on Gemcabene “cannot and will not” be lifted without the additional experimental data requested by the FDA. Notwithstanding the bearish perception by some investors of my article, I also highlighted the clinical potential of gemcabene in dyslipidemia if the hold were to be lifted. In the midst of strategic evaluation, workforce reduction and loan repayment, Gemphire has refocused its clinical program to orphan/rare clinical indications for dyslipidemia. I briefly surmise why this may be the company's best clinical move. What’s New? Gemphire Therapeutics ( GEMP scientific and managerial costly In my first article, I hinted at the lack of objectivity from
Show less
Read more
Impact Snapshot
Event Time:
GEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GEMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GEMP alerts
High impacting GEMPHIRE THERAPEUTICS INC COMMON news events
Weekly update
A roundup of the hottest topics